Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected]
Protocol Library Download
 |
 |
Human CD9/BTCC-1/DRAP-27 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_001769.4)
Cat. No.: pGMPC000682
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CD9/BTCC-1/DRAP-27 Non-Viral expression plasmid (overexpression vector) for mouse CD9 overexpression in unique cell transient transfection and stable cell line development.
Datasheet
Go to
CD9/BTCC-1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMPC000682 |
| Gene Name | CD9 |
| Accession Number | NM_001769.4 |
| Gene ID | 928 |
| Species | Human |
| Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
| Insert Length | 687 bp |
| Gene Alias | BTCC-1,DRAP-27,MIC3,MRP-1,TSPAN-29,TSPAN29 |
| Fluorescent Reporter | Null |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCCGGTCAAAGGAGGCACCAAGTGCATCAAATACCTGCTGTTCGGATTTAACTTCATCTTCTGGCTTGCCGGGATTGCTGTCCTTGCCATTGGACTATGGCTCCGATTCGACTCTCAGACCAAGAGCATCTTCGAGCAAGAAACTAATAATAATAATTCCAGCTTCTACACAGGAGTCTATATTCTGATCGGAGCCGGCGCCCTCATGATGCTGGTGGGCTTCCTGGGCTGCTGCGGGGCTGTGCAGGAGTCCCAGTGCATGCTGGGACTGTTCTTCGGCTTCCTCTTGGTGATATTCGCCATTGAAATAGCTGCGGCCATCTGGGGATATTCCCACAAGGATGAGGTGATTAAGGAAGTCCAGGAGTTTTACAAGGACACCTACAACAAGCTGAAAACCAAGGATGAGCCCCAGCGGGAAACGCTGAAAGCCATCCACTATGCGTTGAACTGCTGTGGTTTGGCTGGGGGCGTGGAACAGTTTATCTCAGACATCTGCCCCAAGAAGGACGTACTCGAAACCTTCACCGTGAAGTCCTGTCCTGATGCCATCAAAGAGGTCTTCGACAATAAATTCCACATCATCGGCGCAGTGGGCATCGGCATTGCCGTGGTCATGATATTTGGCATGATCTTCAGTATGATCTTGTGCTGTGCTATCCGCAGGAACCGCGAGATGGTCTAG |
| ORF Protein Sequence | MPVKGGTKCIKYLLFGFNFIFWLAGIAVLAIGLWLRFDSQTKSIFEQETNNNNSSFYTGVYILIGAGALMMLVGFLGCCGAVQESQCMLGLFFGFLLVIFAIEIAAAIWGYSHKDEVIKEVQEFYKDTYNKLKTKDEPQRETLKAIHYALNCCGLAGGVEQFISDICPKKDVLETFTVKSCPDAIKEVFDNKFHIIGAVGIGIAVVMIFGMIFSMILCCAIRRNREMV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T50574-Ab | Anti-CD9/ BTCC-1/ DRAP-27 monoclonal antibody |
| Target Antigen | GM-Tg-g-T50574-Ag | CD9 VLP (virus-like particle) |
| ORF Viral Vector | pGMAP000191 | Human CD9 Adenovirus plasmid |
| ORF Viral Vector | pGMPC000682 | Human CD9 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMAP000191 | Human CD9 Adenovirus particle |
Target information
| Target ID | GM-T50574 |
| Target Name | CD9 |
|
Gene Group Identifier （Target Gene ID in Homo species) |
928 |
| Gene ID |
100059512 (Equus caballus), 12527 (Mus musculus), 24936 (Rattus norvegicus), 280746 (Bos taurus) 493874 (Felis catus), 611695 (Canis lupus familiaris), 712262 (Macaca mulatta), 928 (Homo sapiens) |
| Gene Symbols & Synonyms | CD9,Cd9,Tspan29,MIC3,MRP-1,BTCC-1,DRAP-27,TSPAN29,TSPAN-29 |
| Target Alternative Names | 5H9 antigen,BTCC-1,CD9,CD9 antigen,Cd9,Cell growth-inhibiting gene 2 protein,DRAP-27,Leukocyte antigen MIC3,MIC3,MRP-1,Motility-related protein (MRP-1),TSPAN-29,TSPAN29,Tetraspanin-29 (Tspan-29),Tspan29,p24 |
| Uniprot Accession |
P21926,P30932,P40239,P40240,P40241
Additional SwissProt Accessions: P40240,P40241,P30932,P40239,P21926 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target |
| Disease | cancer |
| Disease from KEGG | Hematopoietic cell lineage |
| Gene Ensembl | ENSECAG00000003002, ENSMUSG00000030342, ENSBTAG00000014764, ENSCAFG00845029613, ENSMMUG00000004470, ENSG00000010278 |
| Target Classification | Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA) |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.